MedTech Insights report series analyzes the impact of recent
breakthroughs in pulsed-field ablation, signaling its promising
future in the electrophysiology mapping and ablation device
market
LONDON, Dec. 19, 2023 /PRNewswire/ -- Clarivate
Plc (NYSE:CLVT), a global leader in connecting people and
organizations to intelligence they can trust to transform their
world, today announced the launch of a new special report series,
Electrophysiology Mapping and Ablation Devices Market
Insights. The Clarivate MedTech Insights reports reveal new
forecast predictions for the ablation catheter market in four
geographies: the US, Europe,
Japan and Asia Pacific. Findings show pulsed-field
ablation (PFA) is poised to revolutionize the treatment
paradigm.
PFA has emerged as a breakthrough technology for the treatment
of atrial fibrillation, attracting significant investment from
several companies dedicated to its development. This innovative
technique has produced favorable clinical outcomes compared to
existing technologies and has the potential to see immediate
widespread adoption following FDA approval. While both Boston
Scientific and Medtronic have IDE trials for their PFA devices,
Medtronic's PulseSelect PFA system received FDA approval on
December 13, 2023 and Boston
Scientific's FARAPULSE is expected to closely follow. There has
already been a swift adoption of PFA, spurred by the approval of
FARAPULSE in Europe in 2021 and
its subsequent approval in Australia in 2023.
Andrew Lee, Vice President
Medtech, Life Sciences and Healthcare,
Clarivate said: "As the EP mapping and ablation
devices market evolves with the transformative potential of PFA,
medical device companies should understand and analyze the impact
of the recent developments and updates in the field to get a
comprehensive and up-to-date overview of the evolving landscape.
Clarivate experts underscored the potential of PFA and updated our
forecast analysis for the EP mapping and ablation device market,
equipping our customers with the insight and foresight needed to
build informed go-to-market decisions, create innovative medical
devices, deliver them to patients faster and create a healthier
tomorrow.''
This year, the global PFA market value is estimated to be
$232 million with the potential to
grow to $2.9 billion by the year
2028.1 The Electrophysiology Mapping and Ablation
Devices Market Insights reports provide in-depth data and analysis
of clinical practice, patient journey, and competing therapies,
allowing medical device companies and physicians to make more
informed and strategic decisions.
The new reports highlight revised forecasts in the space for
four geographies, covering:
- Electrophysiology Mapping and Ablation Devices – Market
Insights – United States
The US EP mapping and ablation device market, which includes PFA
among other technologies, is projected to experience strong growth
through 2028 and is anticipated to reach a total market value of
$7.2 billion by that year, driven
strongly by PFA uptake. The COVID-19 pandemic had a significant
impact on certain EP ablation procedures in 2020, followed by a
period of recovery. Growth in market revenues will be driven by
increasing ablation procedure volumes and the uptake of
premium-priced devices. Innovations in this space will lead to
improved outcomes and procedure growth.
- Electrophysiology Mapping and Ablation Devices – Market
Insights – Europe
The European EP mapping and ablation device market, projected to
experience moderate growth through 2028 due to increasing ablation
procedure volumes, technological advancements, and the uptake of
premium-priced devices, is anticipated to reach a total market
value of $3.7 billion.
- Electrophysiology Mapping and Ablation Devices – Market
Insights – Japan
The Japanese EP mapping and ablation device market, having largely
recovered from the COVID-19 pandemic, will resume moderate growth
over the remainder of the forecast period. This growth is supported
by increasing AF ablation procedure volumes, the emergence and
adoption of novel technology, including PFA and hybrid AF ablation
systems. The total market value is projected to reach $1.9 billion by the year 2028.
- Electrophysiology Mapping and Ablation Devices – Market
Insights – Asia Pacific
Although the global COVID-19 pandemic negatively impacted the Asia
Pacific EP mapping and ablation device market in 2020, the market
has shown strong recovery and will resume pre-pandemic growth
trends in the near term. Going forward, the Asia Pacific EP mapping
and ablation device market will expand rapidly, supported by rising
AF treatment volumes, an expanding patient pool, improving access
to healthcare, and the emergence of newer, premium-priced devices.
Although cost constraints and a challenging reimbursement
environment will hinder the pace of market expansion to some
extent, the total market value is projected to reach $3.6 billion by the year 2028.
To learn more about MedTech Insights Research Reports, visit
MedTech Insights - Research Reports – Clarivate.
Methodology for the Electrophysiology Mapping and Ablation
Devices Market Insights Reports
Drawing from the expertise of Medtech analysts covering device
segments and geographies across the world paired with proprietary
Clarivate Medtech Intelligence data including Real World Data
assets like claims data and PriceTrack, the Electrophysiology
Mapping and Ablation Devices Market Insights series of reports
provide a comprehensive view of the global market.
About Clarivate
Clarivate is a leading global information services provider. We
connect people and organizations to intelligence they can trust to
transform their perspective, their work and our world. Our
subscription and technology-based solutions are coupled with deep
domain expertise and cover the areas of Academia & Government,
Life Sciences & Healthcare and Intellectual Property. For more
information, please visit clarivate.com
|
1
Source: Clarivate. MedTech 360 Data Explorer. 2023
|
Media Contact:
Luna Ivković
External Communications, Life Sciences & Healthcare
newsroom@clarivate.com
Logo -
https://mma.prnewswire.com/media/1159266/Clarivate_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/clarivate-reveals-stronger-outlook-for-pulsed-field-ablation-market-and-potential-for-device-to-revolutionize-treatment-paradigm-302017572.html